FIELD: biotechnology.
SUBSTANCE: present invention relates to a living attenuated strain of a yellow fever virus, adapted to growth in Vero cells, obtained from a source 17D sub-strain of the yellow fever virus, which is not adapted to growth in Vero cells, where the specified living attenuated strain of the yellow fever virus is less neurovirulent than the specified source 17D sub-strain of the yellow fever virus.
EFFECT: invention expands the arsenal of remedies for protection of patients from an infection of a yellow fever virus.
17 cl, 15 dwg, 18 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT FLAVIVIRAL VACCINES | 2006 |
|
RU2465326C2 |
| CHIMERIC VACCINES BASED ON VIRUSES OF FLAVIVIRUS AND LYSSAVIRUS GENES | 2019 |
|
RU2816136C2 |
| CHIMERIC FLAVIVIRAL VACCINES | 1998 |
|
RU2209082C2 |
| FLAVIVIRUS WITH BIPARTITE GENOME AND USING IT | 2008 |
|
RU2527891C2 |
| VACCINE AGAINST VIRUS OF WEST NILE ENCEPHALITIS | 2003 |
|
RU2376374C2 |
| RECOMBINANT STRAINS OF RESPIRATORY-SYNCYTIAL VIRUS WITH MUTATIONS IN M2-2 ORF, PROVIDING ATTENUATING PHENOTYPE RANGE | 2016 |
|
RU2773746C2 |
| IMMUNOBIOLOGICAL AGENT FOR THE PREVENTION OF DISEASES CAUSED BY TICK-BORNE ENCEPHALITIS VIRUS BASED ON A RECOMBINANT VIRUS OF THE GENUS FLAVIVIRUS | 2022 |
|
RU2795800C1 |
| INACTIVATED POLIO VACCINE | 2011 |
|
RU2599453C2 |
| VACCINE AGAINST FROM WEST NILE ENCEPHALITIS VIRUS | 2002 |
|
RU2283138C2 |
| COMPOSITION FOR PIGS PROTECTION AGAINST PRRS-VIRUS INFECTION (VERSIONS) AND VACCINE CONTAINING SPECIFIED COMPOSITION (VERSIONS) | 2006 |
|
RU2381035C2 |
